Sotera Health Unveils Q1 2025: Financial Performance Breaks New Ground
Financial Performance Highlights: Q1 2025
The company demonstrated resilient financial performance in the first quarter of 2025, with notable achievements across key metrics:
- Net revenues rose 2.6% to $255 million, representing a 4.4% increase on a constant currency basis compared to the same period last year
- Despite the revenue growth, the company experienced a net loss of $13 million, or $0.05 per diluted share, contrasting with the net income of $6 million, or $0.02 per diluted share, in Q1 2024
- Adjusted EBITDA showed strong momentum, increasing 8.8% to $122 million, or an impressive 11.2% on a constant currency basis
- Adjusted Earnings Per Share (EPS) improved to $0.14, marking a $0.01 per diluted share increase from the $0.13 reported in Q1 2024
The company remains confident in its financial trajectory and has reaffirmed its full-year guidance, signaling continued strategic focus and operational efficiency.